Institutional investors purchased a net $7.8 million shares of NVO during the quarter ended December 2013. This may signal that the smart money is gaining interest in this company as the 8.11% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Major industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIERA CAPITAL CORP. (INVESTMENT ... Bought 90.1 Thousand shares of Novo Nordisk A/S
ALTA CAPITAL MANAGEMENT LLC Bought 29.0 Thousand shares of Novo Nordisk A/S
ARDEN ASSET MANAGEMENT LLC Bought 24.4 Thousand shares of Novo Nordisk A/S